Abstract
Massive molecular testing for COVID-19 has been pointed as fundamental to moderate the spread of the disease. Pooling methods can enhance testing efficiency, but they are viable only at very low prevalences of the disease. We propose Smart Pooling, a machine learning method that uses sociodemographic data from patients to increase the efficiency of pooled molecular testing for COVID-19 by arranging samples into all-negative pools. We show efficiency gains of 42% with respect to individual testing at disease prevalence of up to 25%, a regime in which two-step pooling offers marginal efficiency gains. Additionally, we calculate the possible efficiency gains of one- and two-dimensional two-step pooling strategies and present the optimal strategies for disease prevalences up to 25%. We discuss practical limitations to conduct pooling in the laboratory.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding has been received for this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Smart Pooling has been approved by the ethics committee at Universidad de Los Andes in Bogotá, Colombia. The data used in this study have been anonymized and its usage was authorized by the district health department.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We will make our computational platform freely available for the general public in order to optimize COVID-19 testing.
